Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output

The purpose of this study is to examine the various types of international drug price regulation and how that regulation impacts R&D expenditure in specific countries. Conversely, do R&D expenditures ultimately dictate pricing levels within select countries; that is, does a country that has lower R&D investment equate to lower drug prices. This study used a descriptive design that focused on the present condition. The descriptive method includes empirical observation through the use of secondary data analysis on the current conditions. This method was utilized to determine the functional relationship and significant effect of pharmaceutical pricing regulation to R&D investment resulting in decreased product and patent output.